A detailed history of Trust Asset Management LLC transactions in Eli Lilly & CO stock. As of the latest transaction made, Trust Asset Management LLC holds 9,069 shares of LLY stock, worth $7.53 Million. This represents 0.64% of its overall portfolio holdings.

Number of Shares
9,069
Previous 9,069 -0.0%
Holding current value
$7.53 Million
Previous $8.21 Million 2.14%
% of portfolio
0.64%
Previous 0.69%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

May 12, 2023

BUY
$310.63 - $364.82 $27,646 - $32,468
89 Added 0.99%
9,069 $3.11 Million
Q3 2022

Nov 14, 2022

BUY
$296.48 - $337.87 $174,033 - $198,329
587 Added 6.99%
8,980 $2.9 Million
Q2 2022

Aug 10, 2022

BUY
$278.73 - $327.27 $80,831 - $94,908
290 Added 3.58%
8,393 $2.72 Million
Q1 2022

May 10, 2022

BUY
$234.69 - $291.66 $64,070 - $79,623
273 Added 3.49%
8,103 $2.32 Million
Q3 2021

Oct 29, 2021

BUY
$221.6 - $272.71 $113,237 - $139,354
511 Added 6.98%
7,830 $1.81 Million
Q2 2021

Jul 19, 2021

SELL
$180.55 - $233.54 $282,560 - $365,490
-1,565 Reduced 17.62%
7,319 $1.68 Million
Q1 2021

Apr 21, 2021

BUY
$164.32 - $212.72 $186,503 - $241,437
1,135 Added 14.65%
8,884 $1.66 Million
Q4 2020

Jan 27, 2021

BUY
$130.46 - $172.63 $455,696 - $602,996
3,493 Added 82.07%
7,749 $1.31 Million
Q3 2020

Oct 28, 2020

BUY
$146.22 - $169.13 $279,426 - $323,207
1,911 Added 81.49%
4,256 $630,000
Q2 2020

Jul 20, 2020

BUY
$136.42 - $164.18 $319,904 - $385,002
2,345 New
2,345 $385,000
Q4 2018

Feb 13, 2019

SELL
$105.9 - $118.64 $1.45 Million - $1.63 Million
-13,736 Closed
0 $0
Q3 2018

Nov 16, 2018

BUY
$85.86 - $107.31 $1.17 Million - $1.46 Million
13,608 Added 10631.25%
13,736 $33,000
Q1 2018

May 07, 2018

SELL
$74.21 - $87.6 $202,370 - $238,885
-2,727 Reduced 95.52%
128 $10,000
Q3 2017

Nov 01, 2017

BUY
$77.07 - $85.54 $220,034 - $244,216
2,855
2,855 $260,000

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $788B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Trust Asset Management LLC Portfolio

Follow Trust Asset Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Trust Asset Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Trust Asset Management LLC with notifications on news.